Summary
Conventional and molecular cytogenetic analyses of three murine cancer cell lines that had been induced in male athymic mice by the injection of three different human prostate cancer cell lines revealed selective amplification of the Y chromosome. In particular, analysis of metaphase and interphase nuclei by fluorescence in situ hybridization (FISH) with the mouse Y chromosome-specific DNA painting probe revealed the presence of various numbers of Y chromosomes, ranging from one to eight, with a large majority of nuclei showing two copies (46.5–60.1%). In Interphase nuclei, the Y chromosomes showed distinct morphology, allowing identification irrespective of whether the preparations were treated for 15 min or for 5 h with Colcemid, a chemical known to cause chromosome condensation. However, FISH performed on human lymphocyte cultures with chromosome-specific DNA painting probes other than the Y chromosome did not reveal condensed chromosome morphology in interphase nuclei even after 12 h of Colcemid treatment. Our FISH results indicate that (1) the Y chromosome is selectively amplified in all three cell lines; (2) the mouse Y chromosome number is comparable in both interphase and metaphase cells; (3) the Y chromosome number varies between one and eight, with a large majority of cells showing two or three copies in most interphase nuclei; (4) the condensation of the Y chromosome is not affected by the duration of Colcemid treatment but by its inherent DNA constitution; and (5) the number of copies of the Y chromosome is increased and retained not only in human prostate tumor cell lines but also in murine tumors induced by these prostate tumor cell lines.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bowen, J. M.; Cailleau, R.; Giovanella, B.; Pathak, S.; Sciliano, M. J. A retrovirus-producing transformed mouse cell line derived from a human breast adenocarcinoma transplanted in a nude mouse. In Vitro 19:635–641; 1983.
Dave, B. J.; Hopwood, V. L.; Spitz, M. R.; Pathak, S. Sex chromosome abnormalities in lung cancer patients. Cancer Genet. Cytogenet. 87:24–28; 1996.
Fidler, I. J. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev. 5:29–49; 1986.
Goldenberg, D. M.; Pavia, R. A. Malignant potential of murine stromal cells after transplantation of human tumors into nude mice. Science (Wash DC) 212:65–67; 1981.
Gupta, V.; Rajaraman, S.; Eberle, R. Spontaneous induction of malignancy in mouse cells by a human small cell lung cancer implanted in nude mice. Carcinogenesis 11:713–722; 1990.
Hansmann, I. Factors and mechanisms involved in nondisjunction and X-chromosome loss. In: Sandber, A. A., ed. Cytogenetics of mammalian X-chromosome, Part A: basic mechanisms of X-chromosome behavior. New York: Alan R. Liss, Inc.; 1983:131–170.
Heim, S.; Mitelman, F. Cytogenetics of solid tumors. Recent Adv. Histopathol. 15:37–66; 1992.
Johansson, B.; Heim, S.; Mandahl, N.; Mertens, F.; Mitelman, F. Trisomy 7 in nonneoplastic cells. Genes Chromosomes Cancer 6:199–205; 1993.
Johansson, M.; Karauzum, B.; Dietrich, C.; Mandahl, N.; Hambraeus, G.; Johnsson, L.; Clausen, P.; Mitelman, F.; Heim, S. Karyotypic abnormalities in adenocarcinomas of the lung. Int. J. Oncol. 5:17–26; 1994.
Miyamoto, H.; Kato, H.; Ishikuro, A.; Akita, H.; Kawakami, Y. Cytogenetic analysis of lung tumors by in situ hybridization with chromosome specific DNA probes. Nippon Kyobu Shikkan Gakkai Zasshi 30 (Suppl.):33–38; 1992.
Nowinski, G. P.; van Dyke, D. L.; Tilley, B. C.; Jacobsen, G.; Babu, V. R.; Worsham, M. J.; Wilson, G. N.; Weiss, L. The frequency of aneuploidy in cultured lymphocytes is correlated with age and gender but not with reproductive history. Am. J. Hum. Genet. 46:1101–1111; 1990.
Ozen, M.; Multani, A. S.; Chang, S. M.; von Eschenbach, A. C.; Chung, L. W. K.; Pathak, S. Establishment of an in vitro cell model system to study human prostate carcinogenesis: involvement of chromosome 5 in early stages of neoplastic transformation. Int. J. Oncol. 8:883–888; 1996.
Ozen, M.; Multani, A. S.; Kuniyasu, H.; Chung, L. W. K.; von Eschenbach, A. C.; Pathak, S. Specific histologic and cytogenetic evidence for in vivo malignant transformation of murine host cells by three human prostate cancer cell lines. Oncol. Res. 9:433–438; 1997.
Pathak, S. Chromosome banding techniques. J. Reprod. Med. 17:25–28; 1976.
Pathak, S. Cytogenetic abnormalities in cancer: with special emphasis on tumor heterogeneity. Cancer Metastasis Rev. 8:299–318; 1990.
Pathak, S.; Hopwood, V. L.; Babaian, R. J.; Logothetis, C. J.; von Eschenbach, A. C. Chromosome alterations in human prostate cancer: evidence for specific anomalies in lymphocyte cultures [Abstract 946]. In: Proceedings of the American Urological Association Annual Meeting, San Antonio, TX, 1993.
Pathak, S.; Hsu, T. C.; Trentin, J. J.; Butel, J. S.; Panigrahy, B. Nonrandom chromosome abnormalities in transformed Syrian hamster cell lines. In: Arrighi, F. E.; Rao, P. N.; Stubblefield, E., ed. Genes, chromosomes, and neoplasia. New York: Raven Press; 1981:405–418.
Pathak, S.; Nemeth, M. A.; Multani, A. S.; Thalmann, G. N.; von Eschenbach, A. C.; Chung, L. W. K. Can cancer cells transform normal host cells into malignant cells? Br. J. Cancer 76:1134–1138; 1997.
Pettaway, C. A.; Pathak, S.; Greene, G.; Ramierez, E.; Wilson, M. R.; Killion, J. J.; Fidler, I. J. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin. Cancer Res. 2:1627–1636; 1996.
Sandberg, A. A. The chromosomes in human cancer and leukemia. 2nd ed. New York: Elsevier Science Publishing; 1990.
Thalmann, G. N.; Anezinis, P. E.; Chang, S.-M.; Zhau, H. E.; Kim, E. E.; Hopwood, V. L.; Pathak, S.; von Eschenbach, A. C.; Chung, L. W. K. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res. 54:2577–2581; 1994.
Tricoli, J. V.; Bracken, R. B. ZFY gene expression and retention in human prostate adenocarcinoma. Genes Chromosomes Cancer 6:65–72; 1993.
Wu, H.-C.; Hsieh, J.-T.; Gleave, M. E.; Brown, N. M.; Pathak, S.; Chung, L. W. K. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int. J. Cancer 57:406–412; 1994.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Multani, A.S., Ozen, M., Agrawal, A. et al. Amplification of the Y chromosome in three murine tumor cell lines transformed in vivo by different human prostate cancers. In Vitro Cell.Dev.Biol.-Animal 35, 236–239 (1999). https://doi.org/10.1007/s11626-999-0032-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11626-999-0032-6